Daxor ROE 2010-2011 | DXR
Current and historical return on equity (ROE) values for Daxor (DXR) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Daxor ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2011-12-31 | $-0.01B | $0.04B | -14.46% |
| 2011-09-30 | $-0.00B | $0.04B | -6.78% |
| 2011-06-30 | $0.00B | $0.05B | 8.56% |
| 2011-03-31 | $0.00B | $0.05B | 8.70% |
| 2010-12-31 | $0.01B | $0.05B | 10.81% |
| 2010-09-30 | $0.00B | $0.05B | 4.30% |
| 2010-06-30 | $0.00B | $0.04B | 4.26% |
| 2010-03-31 | $0.01B | $0.05B | 16.84% |
| 2009-12-31 | $0.01B | $0.05B | 13.71% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.040B | $0.000B |
| Daxor Corporation is a medical device manufacturing corporation with additional biotech services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $20.128B | 0.00 |
| Quest Diagnostics (DGX) | United States | $16.942B | 17.17 |
| DaVita (DVA) | United States | $12.579B | 16.27 |
| Encompass Health (EHC) | United States | $9.173B | 21.63 |
| Chemed (CHE) | United States | $7.854B | 24.14 |
| Elanco Animal Health (ELAN) | United States | $5.650B | 13.45 |
| RadNet (RDNT) | United States | $5.092B | 112.75 |
| Option Care Health (OPCH) | United States | $4.083B | 19.35 |
| Amedisys (AMED) | United States | $3.010B | 21.42 |
| LifeStance Health (LFST) | United States | $2.958B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.273B | 26.67 |
| Astrana Health (ASTH) | United States | $1.658B | 22.68 |
| U.S Physical Therapy (USPH) | United States | $1.313B | 34.52 |
| Pennant (PNTG) | United States | $0.887B | 35.86 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.871B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.252B | 0.00 |
| Bioqual (BIOQ) | United States | $0.058B | 0.00 |
| Ontrak (OTRK) | United States | $0.007B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.005B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.003B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |